Inaktiver Wert

Andere Sprachen ImmunoGen, Inc.

Aktien

878613

US45253H1014

IMGN

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

AbbVie CEO to Retire; COO Robert Michael Named Successor	20.02.
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	13.02.
Biopharma Credit Secures $51 Million Loan Repayment from US Biotech ImmunoGen	13.02.
ImmunoGen, Inc.(NasdaqGS:IMGN) dropped from S&P Global BMI Index	13.02.
ImmunoGen, Inc.(NasdaqGS:IMGN) dropped from S&P TMI Index	13.02.
ImmunoGen, Inc.(NasdaqGS:IMGN) dropped from S&P Biotechnology Select Industry Index	13.02.
Top Stories at Midday: Bezos Sells Nearly 12 Million Amazon Shares; Diamondback's $26 Billion Endeavor Energy Deal; Citigroup's Risk Management Procedures Rebuked; AbbVie Buys ImmunoGen	12.02.
AbbVie Completes $10.1 Billion Acquisition of ImmunoGen, Lowers Q1 Adjusted EPS Guidance	12.02.
Diamondback Energy : Abbvie, Diamondback Energy, Gilead...les valeurs à suivre aujourd'hui à Wall Street	12.02.
Abbvie : abaisse ses perspectives après le rachat d'Immunogen	12.02.
AbbVie Acquires ImmunoGen for $31.26 per Share	12.02.
AbbVie : acquisition d'ImmunoGen finalisée	12.02.
Immunogen, Inc. Announces Board Changes	12.02.
AbbVie Completes Acquisition of ImmunoGen	12.02.
ImmunoGen, Inc.(NasdaqGS:IMGN) dropped from NASDAQ Composite Index	12.02.
AbbVie Inc. completed the acquisition of ImmunoGen, Inc. from Redmile Group, LLC, RA Capital Management, L.P., BlackRock, Inc., State Street Corporation, The Vanguard Group, Inc. and others.	12.02.
ImmunoGen, Inc.(NasdaqGS:IMGN) dropped from NASDAQ Biotechnology Index	09.02.
ImmunoGen Insider Sold Shares Worth $352,391, According to a Recent SEC Filing	07.02.
ImmunoGen Insider Sold Shares Worth $588,733, According to a Recent SEC Filing	07.02.
AbbVie 4Q Sales Lower as Himura Revenue Sinks	02.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ImmunoGen, Inc.

Aktien

878613

US45253H1014

IMGN

Andere Sprachen

Filter